Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era-Reference-Cited by-同舟云学术

Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era

Published:2022-12-08 Issue:1 Volume:41 Page:97-107
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Vassilakopoulos Theodoros P.¹^ORCID,Panitsas Fotios¹^ORCID,Mellios Zois²,Apostolidis John³^ORCID,Michael Michalis⁴,Gurion Ronit⁵,Ferhanoglu Burhan⁶^ORCID,Hatzimichael Eleftheria⁷,Karakatsanis Stamatios⁸,Dimou Maria¹^ORCID,Kalpadakis Christina⁹,Katodritou Eirini¹⁰,Leonidopoulou Theoni¹¹,Kotsianidis Ioannis¹²,Giatra Hara²,Kanellias Nick¹³,Sayyed Ayman³,Tadmor Tamar¹⁴^ORCID,Akay Olga Meltem⁶,Angelopoulou Maria K.¹^ORCID,Horowitz Netanel¹⁵,Bakiri Maria²,Pangalis Gerassimos A.¹¹⁶,Panayiotidis Panayiotis¹,Papageorgiou Sotirios G.¹⁷^ORCID

Affiliation:

1. Department of Haematology and Bone Marrow Transplantation National and Kapodistrian University of Athens Laikon General Hospital Athens Greece

2. Department of Haematology and Lymphoma Evangelismos General Hospital Athens Greece

3. Department of Adult Hematology & Stem Cell Transplantation Lymphoma Program King Fahad Specialist Hospital Dammam Saudi Arabia

4. Department of Haematology Nicosia General Hospital Nicosia Cyprus

5. Rabin Medical Center Tel Aviv University Tel Aviv Israel

6. Hematology Department Koç University School of Medicine Istanbul Turkey

7. Department of Haematology Faculty of Medicine School of Health Sciences University of Ioannina Ioannina Greece

8. Third Department of Internal Medicine National and Kapodistrian University of Athens Sotiria Hospital Athens Greece

9. Department of Haematology University of Crete Iraklion Greece

10. Department of Haematology Theagenion Anticancer General Hospital Thessaloniki Greece

11. Department of Haematology Sismanoglion General Hospital Athens Greece

12. Department of Haematology Democritus University of Thrace Alexandroupolis Greece

13. Department of Therapeutics National and Kapodistrian University of Athens Alexandra Hospital Athens Greece

14. Bnai Zion Medical Center Haifa Israel

15. Rambam Medical Center Haifa Israel

16. Department of Haematology Athens Medical Center Psychikon Branch Athens Greece

17. Second Propaedeutic Department of Internal Medicine National and Kapodistrian University of Athens Attikon Hospital Athens Greece

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3096

Reference38 articles.

1. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

2. Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease

3. Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature;Leukemia & Lymphoma;2024-09-03

2. Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Isolated central nervous system relapse in two adolescents with primary mediastinal large B‐cell lymphoma after treatment with R‐DA‐EPOCH;Pediatric Blood & Cancer;2024-05-09

4. Relapse of primary mediastinal B-cell lymphoma with isolated central nervous system involvement: risk factors and search for personalized therapy;P.A. Herzen Journal of Oncology;2024

5. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12